Emmaus Life Sciences Inc
(EMMA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 16,653 | 29,597 | 18,390 | 20,610 | 23,167 |
| Cost of Goods | 1,201 | 1,342 | 2,588 | 3,312 | 2,248 |
| Gross Profit | 15,452 | 28,255 | 15,802 | 17,298 | 20,919 |
| Operating Expenses | 17,547 | 25,057 | 22,976 | 23,738 | 21,199 |
| Operating Income | -1,894 | 3,540 | -6,586 | -6,128 | -32 |
| Interest Expense | 5,492 | 7,383 | 5,013 | 3,101 | 5,989 |
| Other Income | 962 | 51 | 1,034 | -6,692 | 6,994 |
| Pre-tax Income | -6,424 | -3,792 | -10,565 | -15,921 | 973 |
| Income Tax | 29 | -59 | 60 | 25 | -381 |
| Net Income Continuous | -6,453 | -3,733 | -10,625 | -15,946 | 1,354 |
| Net Income | $-6,453 | $-3,733 | $-10,625 | $-15,946 | $1,354 |
| EPS Basic Total Ops | -0.10 | -0.07 | -0.21 | -0.32 | 0.03 |
| EPS Basic Continuous Ops | -0.10 | -0.07 | -0.21 | -0.32 | 0.03 |
| EPS Diluted Total Ops | -0.10 | -0.07 | -0.21 | -0.32 | 0.03 |
| EPS Diluted Continuous Ops | -0.10 | -0.07 | -0.21 | -0.32 | 0.03 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.07 | -0.21 | -0.32 | 0.02 |
| EBITDA(a) | $-1,164 | $6,140 | $-4,718 | $-4,259 | $4,055 |